ImmunoPrecise Antibodies (IPA) Completes At-the-Market Equity Offering and Fully Converts Yorkville Debenture
Charmingly Eccentric and Full of Personality: ImmunoPrecise Antibodies Ltd. Completes Equity Offering Program Strategic ATM Offering Raises USD $7.0 Million Util ImmunoPrecise Antibodies Ltd. (“IPA” or the “Company”) has made waves in the biotechnology industry with the successful completion of its USD $8.8 million “at-the-market” equity offering program (the “ATM Program”). This achievement marks a…